BZKF Translationsgruppe - Determination of residual disease in AML using AI-supported analysis of flow cytometry data (AML-MRD)

Third party funded individual grant


Acronym: AML-MRD

Start date : 01.01.2025

End date : 31.12.2026

Project details

Involved:

Stefan Krause Project Leader David Blumenthal Project Leader Paul Martini Project Member

Contributing FAU Organisations:

Department of Medicine 5 – Haematology and Oncology Professur für Biomedical Network Science

Funding Source

andere Förderorganisation Bayerisches Zentrum für Krebsforschung (BZKF)